All In Biotech

Drug Trial Radar · NCT02388984

Phase III Study of Compound Danshen Dripping Pills to Treat Diabetic Retinopathy

A Randomized, Double Blind, Multi-Center Study of Compound Danshen Dripping Pills in Patients With Diabetic Retinopathy (Syndrome Of Qi-Stagnation and Blood Stasis)

Last checked: Nov 19, 2026Latest source record: Mar 21, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. Randomized with 480 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

480

Planned (sponsor's estimate)

Start

May 2013

Primary completion

May 2017

Study completion Dec 2017

Sponsor

Lead sponsor
Tasly Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
Mar 17, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 30 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy and safety of Compound Danshen Dripping Pills in patients with diabetic retinopathy(Syndrome Of Qi-Stagnation and Blood Stasis).

Conditions

  • Non-proliferative Diabetic Retinopathy

Interventions

  • Compound danshen dripping pillsDrug

    Dosage form:pill. Dosage:20pills. Frequency:three times per day. Duration:24 weeks.

  • PlaceboDrug

    Dosage form:pill. Dosage:20pills. Frequency:three times per day. Duration:24 weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The total effective rate of Fundus changes, the severity of diabetic retinopathy change from baseline at the end of week 24 compared to placeboTime frame: 24weeks

Locations

16 sites in 1 country. Site status is shown where the registry gives one.

  • Guang'anmen Hospital of China Academy of Chinese Medical Sciences

    Beijing, Beijing Municipality, China

  • Dongfang Hospital, Beijing University of Chinese Medicine

    Beijing, Beijing Municipality, China

  • Southwest Hospital, Third Military Medical University

    Chongqing, Chongqing Municipality, China

  • The First Affiliated Hospital of Guangzhou University of TCM

    Guangzhou, Guangdong, China

  • The First Affiliated Hospital of Guangxi Medical University

    Nanning, Guangxi, China

  • Henan Institute of Ophthalmology

    Zhengzhou, Henan, China

  • Hubei Provincial Hospital of TCM

    Wuhan, Hubei, China

  • Union Hospital, Tongji Medical College,Huazhong University of Science and Technology

    Wuhan, Hubei, China

  • The First Hospital of Hunan University of Chinese Medicine

    Changsha, Hunan, China

  • Jiangsu Province Hospital of TCM

    Nanjing, Jiangsu, China

  • Jiangxi Provincial People's Hospital

    Nanchang, Jiangxi, China

  • The Affiliated Hospital of Changchun University of Chinese Medicine

    Changchun, Jilin, China

  • Shenyang He Eye Hospital

    Shenyang, Liaoning, China

  • Yantai Yuhuangding Hospital

    Yantai, Shandong, China

  • Shanghai General Hospital

    Shanghai, Shanghai Municipality, China

  • Teaching Hospital of Chengdu University of TCM

    Chengdu, Sichuan, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.